Generate a tailored SOP for Dr. Paul Ekert. Improve your application with a focused, well-structured draft.
Paul Ekert is a clinician scientist with 25 years of experience as a consultant paediatrician specializing in oncology research. He is appointed to the Children’s Cancer Institute, leading the Translational Tumour Biology group and holds cross-appointments at the Peter MacCallum Cancer Centre and the Murdoch Children’s Research Institute (MCRI). His research focuses on the genetic understanding of paediatric cancers, particularly in developing novel therapeutic targets. Ekert's work involves building research programs that utilize RNA sequencing of patient samples, specifically targeting childhood Acute Lymphoblastic Leukaemia. His group's goals include leading national initiatives for paediatric personalized medicine and expanding the cancer genomics research portfolio. In 2019, he became the Group Leader at the Children’s Cancer Institute, where he drives efforts to investigate the molecular biology of cancers and develop targeted treatments. His research interests include discovering new oncogenic fusions in childhood cancer, utilizing functional genomics to define oncogenic pathways, and understanding the immune microenvironment in high-risk paediatric cancers.
Children's Cancer Institute • Sydney, Australia
Leads research and initiatives focused on paediatric cancer and genomics.
Murdoch Children’s Research Institute • Melbourne, Australia
Established a new molecular cancer research program linked to clinical services.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.